Jan 26, 2022· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2021-P-0523-0019
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2021-P-0523
Requests that the FDA revert to its longstanding policy of allowing manufacturers to market dietary supplements containing NAC and rescind the legally invalid position included in warning letters11 that NAC is precluded by section 201(ff)(3)(B)(i) of the FDCA from being a legal dietary ingredient in dietary supplements; CLOSED
RIN
—
Last modified
Mar 31, 2022
Comment window
—
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Jan 26, 2022 and Jan 26, 2022. 0 other organizations filed here.
What Consumer Healthcare Products Association filed (1)
Abstract
CLOSED
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%